Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

Composite photo shows Japanese Lasker Award winners (from L) Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co., and Masashi Yanagisawa, a professor at the University of Tsukuba. The Chugai researchers received the clinical medical research award for developing a hemophilia treatment, while Yanagisawa won the basic medical research award for identifying orexin and linking its deficiency to narcolepsy.

Japanese winners of U.S. Lasker Award

TOKYO, Japan, Sept. 10 Kyodo - Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia. (Kyodo)

Japanese winner of U.S. Lasker Award

Japanese winner of U.S. Lasker Award

Japanese researcher Takehisa Kitazawa of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Kitazawa shared the award with fellow Chugai researchers Kunihiro Hattori and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.

Japanese winner of U.S. Lasker Award

Japanese winner of U.S. Lasker Award

Japanese researcher Tomoyuki Igawa of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Kitazawa shared the award with fellow Chugai researchers Kunihiro Hattori and Takehisa Kitazawa for their contributions to the development of a treatment for hemophilia.

Japanese winner of U.S. Lasker Award

Japanese winner of U.S. Lasker Award

Japanese researcher Kunihiro Hattori of Chugai Pharmaceutical Co. attends a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research. Hattori shared the award with fellow Chugai researchers Takehisa Kitazawa and Tomoyuki Igawa for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. pose for a photo during a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.

Japanese winners of U.S. Lasker Award

Japanese winners of U.S. Lasker Award

(From L) Japanese researchers Takehisa Kitazawa, Kunihiro Hattori and Tomoyuki Igawa of Chugai Pharmaceutical Co. attend a press conference in Tokyo on Sept. 10, 2026, after receiving the Lasker Award for clinical medical research for their contributions to the development of a treatment for hemophilia.